@FierceMedDev: Medtronic scores promising results for next-gen stent graft. Story | Follow @FierceMedDev
@MarkHFierce: A Belgian company snagged some new funding for an interesting ophthalmic device, tech spun out of a Seattle outfit. Item | Follow @MarkHFierce
@MichaelGFierce: FDA allows pivotal trial of Actinium's armed-antibody isotope delivery. More from FierceDrugDelivery | Follow @MichaelGFierce
> Smith & Nephew ($SNN) rolled out a new e-learning platform to help surgeons teach themselves and each other about various techniques, targeting joint repair and replacement, extremities and trauma specialties. Item
> Germany's Biotronik won FDA approval to expand a U.S. clinical trial that will test whether its Entovis pacemaker systems and Setrox leads can safely withstand an MRI scan. Item
> Xenex Disinfection Services nailed down $11.3 million in new funding from the likes of Battery Ventures and others to help it expand development and marketing of a device that uses special ultraviolet light to destroy pathogens that cause hospital-related infections. Item
> A New Jersey cardiologist was sentenced to more than 6 years in prison in a massive Medicare fraud scheme that involved, in part, massive orders for blood tests for all of his patients whether or not they needed them. Item
> Bacterin International's ($BONE) OsteoSponge showed promise in a clinical trial using it as a bone graft substitute during a spinal fusion procedure. Item
Biotech News
@FierceBiotech: FDA sets up roadblock for Forest, Richter, rejecting #schizophrenia drug. Story | Follow @FierceBiotech
@JohnCFierce: GlaxoSmithKline politely dumps $230M Fabry drug deal with Amicus. News | Follow @JohnCFierce
@DamianFierce: Icahn buys into Hologic; Hologic swallows 10% poison pill. Release | Follow @DamianFierce
@EmilyMFierce: Imagining the Post-Antibiotics Future. Feature (via Medium) | Follow @EmilyMFierce
> Pfizer, GlaxoSmithKline forge cancer alliance in combo melanoma trial pact. More
> Flagship Ventures launches a biotech on the human microbiome sea. News
> Array slides as longtime CSO finds the exit. Item
Pharma News
@FiercePharma: Wednesday's best-read story (still): Will Teva find a partner to save it from itself? More | Follow @FiercePharma
@EricPFierce: 350 sales folks get the ax as Actavis trims US force post Warner Chilcott merger. Story | Follow @EricPFierce
@CarlyHFierce: Roche's Kadcyla approved in the EU for advanced HER2-positive breast cancer. Release | Follow @CarlyHFierce
> Vimizim panel nod fuels new BioMarin buyout buzz. Story
> Forest's antipsychotic ambitions thwarted by FDA delay. More
> Pfizer whacks plant as generics eat sales. News
Vaccines News
> European Union prepares to back vaccine stability project. News
> China's climate diversity creates flu vaccination complications. More
> WHO updates malaria roadmap with 2030 vaccine goals. Article
> U.S. gathers vaccine researchers to talk bioterrorism threat Q fever. Story
> CDC to import unapproved Novartis vaccine to stem Princeton meningitis outbreak. Piece
Pharma Manufacturing News
> JLL lines up financing for $2.6B Patheon, DSM deal. More
> GE Oslo plant gets FDA OK for new heart imaging product. News
> Pfizer to close Puerto Rico plant. Story
> Actavis puts California plant on hit list. Article
> Unilife grabs $40M contract to fill Hikma injectables. More